Atlas Trials

Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection

Clinical trial NCT06341686 · UNKNOWN

Trial details

NCT number
NCT06341686
Sponsor
Hospital do Rim e Hipertensão
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
CMV Infection
Start date
2024-05-05
Primary completion
2025-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.